Abstract
Background Blood Pressure Variability (BPV) is associated with cardiovascular risk and serum uric acid level. We investigated whether BPV is lowered by allopurinol and whether it is related to markers of cerebral small vessel disease.
Methods We used data from a randomised, double-blind, placebo-controlled trial of two years allopurinol treatment after recent ischemic stroke or transient ischaemic attack. Visit-to-visit BPV was assessed using brachial blood pressure (BP) recordings. Short-term BPV was assessed using ambulatory BP monitoring (ABPM) performed at 4 weeks and 2 years. Brain MRI was performed at baseline and 2 years. BPV measures were compared between the allopurinol and placebo groups and with white matter hyperintensity progression.
Results 409 participants were included (205 allopurinol; 204 placebo) were included in analyses of visit-to-visit BPV and there were no significant differences between groups. 196 participants were included in analyses of short-term BPV at week 4. Two measures were reduced by allopurinol: the standard deviation (SD) of systolic BP (by 1.30mmHg (95% confidence interval (CI) 0.18–2.42, p=0.023)); and the average real variability (ARV) of systolic BP (by 1.31mmHg (95% CI 0.31–2.32, p=0.011)). There were no differences in other measures at week 4 or in any measure at 2 years.
Conclusions Allopurinol treatment did not affect visit-to-visit BPV in people with recent ischemic stroke or TIA. Two BPV measures were reduced at week 4 by allopurinol but not at 2 years. Allopurinol is unlikely to lead to an important reduction in BPV in people with ischemic stroke or TIA.
Competing Interest Statement
AS holds a patent for the use of xanthine oxidase inhibition for the treatment of angina pectoris. DD received payment for image analysis in this study. The other authors declare they have no competing interests.
Clinical Trial
ClinicalTrials.gov NCT02122718
Clinical Protocols
https://pubmed.ncbi.nlm.nih.gov/30246149/
Funding Statement
XILO-FIST was financially supported by a joint Stroke Association and British Heart Foundation Programme Grant (ref: TSA BHF 2013/01).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
XILO-FIST was approved by the UK MHRA and NHS Research Ethics Committee (REC number 14/WS/0113)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The datasets analysed that support the findings of the present study are available from the corresponding author upon reasonable request.
Non-standard Abbreviations and Acronyms
- ABPM
- Ambulatory blood pressure monitoring
- ARV
- Average real variability
- BMI
- Body mass index
- BP
- Blood pressure
- BPV
- Blood pressure variability
- CI
- Confidence interval
- CV
- Coefficient of variation
- DBP
- Diastolic blood pressure
- IQR
- Interquartile Range
- MoCA
- Montreal cognitive assessment
- MRI
- Magnetic resonance imaging
- NIHSS
- National institute of health stroke scale
- SBP
- Systolic blood pressure
- SD
- Standard deviation
- TIA
- Transient ischemic attack
- VIM
- Variation independent of the mean
- WMH
- White matter hyperintensity
- XILO-FIST
- Xanthine oxidase inhibition for the improvement of long-term outcomes following ischemic stroke and transient ischemic attack
